Ilaprazole: Distinctive pharmacokinetic and pharmacodynamic properties among proton pump inhibitors
Ilaprazole is a new proton pump inhibitor (PPI) that provides effective and sustained intragastric acid suppression. As PPIs are foundational medications in the treatment of acid-related disorders, the introduction of new PPIs into clinical practice is encouraged. Despite dose and frequency adjustme...
Saved in:
| Main Authors: | Hubert Igno Castus, Bhuvaneshwar Amanan, Hariharan Murugadoss, Priyadharshini Ananthathandavan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-07-01
|
| Series: | Gastroenterology & Endoscopy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949752325000536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Computational drug–drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel
by: Priyadharshini Ananthathandavan, et al.
Published: (2024-12-01) -
Role of the CYP450 Enzymatic Pathway in Drug Metabolism: Focus on Proton-pump Inhibitors and Antiplatelet Therapy
by: Ashwani Mehta, et al.
Published: (2025-01-01) -
Pharmacokinetic evaluation of the interaction between oral kaempferol and ethanol in rats
by: Zhou Zhaoxiang, et al.
Published: (2016-12-01) -
Integrating Cytochrome P450-Mediated Herbicide Tolerance into Anthocyanin-Rich Maize Through Conventional Breeding
by: Sergio Arias-Martínez, et al.
Published: (2025-05-01) -
Prospective Trial on the Pharmacokinetics of Clopidogrel in Hemodialysis Patients
by: Juergen Grafeneder, et al.
Published: (2024-10-01)